XELLIA PHARMACEUTICALS ApS
CVR 61094628 · Private limited company (ApS) · Active · Low risk
XELLIA PHARMACEUTICALS ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry fremstilling af farmaceutiske råvarer. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 404.6m and a net result of DKK 213.7m. CEO: Michael Kocher.
Bankruptcy risk for XELLIA PHARMACEUTICALS ApS
0.0%
probability of bankruptcy within 12 months
Low risk
0.0 × the average (1.41%) · higher risk than 0% of active Danish companies
Lowest riskHighest risk
Increases the risk
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Current ratio50%–100% · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Reduces the risk
Reporting classReporting class C, large enterprise · bankruptcy rate 0.2%0.03×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Employees (latest year)100+ · bankruptcy rate 2.3%0.27×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 61094628
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (67 years)
- Address
- Dalslandsgade 11
2300 København S - Municipality
- København
- Industry
- Fremstilling af farmaceutiske råvarer (211000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 201.0m
- Employees
- 595 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 31 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 14.3% |
| Current ratio | 52% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 24 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 1.5bn | DKK 1.6bn |
| Gross profit | DKK 314.9m | DKK 37.0m |
| Net profit | DKK 213.7m | DKK 829.0m |
| Equity | DKK 404.6m | DKK 162.5m |
| Total assets | DKK 2.8bn | DKK 3.2bn |
| Cash | DKK 160.4m | – |
| Short-term debt | DKK 1.9bn | – |
| Tax owed | DKK 31.0m | – |
| Avg. employees | 453 | – |
Latest annual report: Reporting class C, large enterprise · auditor's statement: Auditor's report on audited financial statements · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 163 | ||
| 1 Jan 2024 – 31 Dec 2024 | 169 | ||
| 1 Jan 2023 – 31 Dec 2023 | 180 | ||
| 1 Jan 2022 – 31 Dec 2022 | 128 | ||
| 1 Jan 2021 – 31 Dec 2021 | 115 | ||
| 1 Jan 2020 – 31 Dec 2020 | 124 | ||
| 1 Jan 2019 – 31 Dec 2019 | 128 | ||
| 1 Jan 2018 – 31 Dec 2018 | 115 | ||
| 1 Jan 2017 – 31 Dec 2017 | 106 | ||
| 1 Jan 2016 – 31 Dec 2016 | 152 | ||
| 1 Jan 2015 – 31 Dec 2015 | 143 | ||
| 1 Jan 2014 – 31 Dec 2014 | 159 | ||
| 1 Jan 2013 – 31 Dec 2013 | 139 | ||
| 1 Jan 2012 – 31 Dec 2012 | 83 | ||
| 1 Jan 2011 – 31 Dec 2011 | 145 | ||
| 1 Jan 2010 – 31 Dec 2010 | 159 | ||
| 1 Jan 2009 – 31 Dec 2009 | 125 | ||
| 1 Jan 2008 – 31 Dec 2008 | 162 | ||
| 1 Jan 2007 – 31 Dec 2007 | 160 | ||
| 1 Jan 2006 – 31 Dec 2006 | 164 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Michael Kocher | Current | |
| CEO | Niels Lykke Graugaard | ||
| CEO | Gerner Vejrup | ||
| CEO | Thor Kristiansen | ||
| CEO | Ingrid Beichmann Wiik | ||
| CEO | Carl-Åke Carlsson | ||
| CEO | Torben Jung Laursen | ||
| CEO | Lis Else Kirkegaard | ||
| CEO | Terje Aarbogh | ||
| CEO | Finn Gjersøe | ||
| CEO | Svend Andersen | ||
| CEO | Steen Asferg Rasmussen | ||
| CEO | Mikkel Lyager Olsen | ||
| Board | Lars Beck Madsen | Current | |
| Board | Søren Hostrup | Current | |
| Board | Lone Thiis | Current | |
| Board | Martin Bech | Current | |
| Board | Michael Uhd | Current | |
| Board | Eva Blem | Current | |
| Board | Alexander Sebastian Benjamin Sproedt | Current | |
| Board | Niels Søby | ||
| Board | Per Rønsted | ||
| Board | Hans Christian Hansen | ||
| Board | Hans Christian Hansen | ||
| Board | Jacob Kortleven Holm | ||
| Board | Johan Jesper Laier | ||
| Board | Hans Bruun Ringsing | ||
| Board | Niels Lykke Graugaard | ||
| Board | Aage Ole Egholm Larsen | ||
| Board | Einar Wilhelm Sissener | ||
| Board | Otto Feierskov Andreasen | ||
| Board | Astrid Spillum | ||
| Board | Flemming Bogø Jensen | ||
| Board | Jørgen Worning | ||
| Board | Tim Niss Corell | ||
| Board | Elsebeth Heldorf Knudsen | ||
| Board | Elsebeth Heldorf Knudsen | ||
| Board | Ole Mulvad | ||
| Board | Flemming Riber Larsen | ||
| Board | Jette Elisabeth Skylark | ||
| Board | Preben Sigvard Franch Schrøder | ||
| Board | Gitte Lisbeth Kofod | ||
| Board | Charlotte Hemmingsen | ||
| Board | Oscar William Kaalstad | ||
| Board | Roald Jøtun | ||
| Board | Isadore Roy Cohen | ||
| Board | Charles Arthur Baker | ||
| Board | William P Altman | ||
| Board | Jack van Hulst | ||
| Board | Ricardo Pedro Storm | ||
| Board | Jeffrey Edward Smith | ||
| Board | Jeffrey Edward Smith | ||
| Board | Gerner Vejrup | ||
| Board | Thor Kristiansen | ||
| Board | Torben Koch | ||
| Board | Torben Koch | ||
| Board | Jette Elisabeth Skylark | ||
| Board | Jette Elisabeth Skylark | ||
| Board | Lise Sylvest Helledi | ||
| Board | Sverre Bjertnes | ||
| Board | Sverre Bjertnes | ||
| Board | Torben Jung Laursen | ||
| Board | Thor Kristiansen | ||
| Board | Lars Saaby Nielsen | ||
| Board | Søren Peter Thomsen | ||
| Board | Finn Gjersøe | ||
| Board | Henriette Nielsen | ||
| Board | Michael Graakjær | ||
| Board | Hans Ketel Ohm Laursen | ||
| Board | Ingrid Beichmann Wiik | ||
| Board | Bente Schmidt Nielsen | ||
| Board | Steen Asferg Rasmussen | ||
| Board | Torben Jung Laursen | ||
| Board | Torben Koch | ||
| Board | Gert Ibsen | ||
| Board | Frank Jensen | ||
| Board | Anette Melchior Jensen | ||
| Board | Stig Jarle Pettersen | ||
| Board | Kennet Ingvar Lundberg | ||
| Board | Mikkel Lyager Olsen | ||
| Board | Carl-Åke Carlsson | ||
| Board | Jakob Toft Mossing | ||
| Board | Jakob Toft Mossing | ||
| Board | Jan Høgh Bergmann | ||
| Board | Susanne Lisby | ||
| Board | Lennart Bo Fredmark | ||
| Board | Thomas Schou Hunderup | ||
| Board | Mads Bodenhoff | ||
| Board | Lars Mosberg | ||
| Board | Lennart Bo Fredmark | ||
| Board | Lone Finner | ||
| Board | Niels Murmann | ||
| Board | Lone Thiis | ||
| Board | Thomas Schou Hunderup | ||
| Board | Jakob Christian Andersen | ||
| Board | Lone Thiis | ||
| Board | Gisli Lukas Ihlemann Lundahl | ||
| Board | Geelanie Rodriguez Briones | ||
| Board | John Ramsay Stewart | ||
| Board | Michael Kocher | ||
| Board | Thomas Clement Guldager | ||
| Owner (100%) | XELLIA GROUP ApS | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | BDO Holding VII, statsautoriseret revisionsaktieselskab | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB |
The CEOs' other companies
Niels Lykke Graugaard – 31 other companies, of which 3 bankrupt
- Aktieselskabet af 17. juli 2017 Bankrupt 31 Jul 2017
- ENVIKRAFT A/S Bankrupt 9 Nov 2017
- ENVIKRAFT INVEST A/S Bankrupt 9 Nov 2017
- 14. oktober 2013 A/S Opløst
- A.L - PHARMA ApS Fusioneret
- ALK-ABELLÓ A/S Active
- ALM A/S Opløst
- ATHCO-ENGINEERING A/S Active
- DANICE SERVICES A/S Fusioneret
- DANSK TETRA LAVAL HOLDING A/S Fusioneret
- DIAGNOSELABORATORIET AF 1977 A/S Opløst
- DSI Dantech Holding A/S Active
- FMC A/S Active
- Freeze BidCo ApS Active
- Freeze HoldCo ApS Active
- GEA FOOD SOLUTIONS NORDIC A/S Active
- GEA LIQUID PROCESSING SCANDINAVIA A/S Fusioneret
- GEA PROCESS ENGINEERING A/S Active
- GEH INVEST ApS Active
- GRAM EQUIPMENT A/S Active
- GRAM EQUIPMENT HOLDING ApS Fusioneret
- Kildegården Holding ApS Active
- MONBERG & THORSEN A/S Fusioneret
- MT Højgaard Danmark A/S Active
- NIRO-143 A/S Opløst
- NIRO-BOLA A/S Opløst
- ORIGIO A/S Active
- TETRA LAVAL FINANS ApS Opløst
- TETRA PAK PROCESSING SYSTEMS A/S Active
- THORBJØRN CHRISTENSEN A/S Fusioneret
Gerner Vejrup – 1 other companies
- A.L - PHARMA ApS Fusioneret
Torben Jung Laursen – 8 other companies, of which 2 bankrupt
- 2TALINVEST ApS Bankrupt 9 Feb 2012
- NORDIC MEDICAL SUPPLY A/S Bankrupt 22 Dec 2011
- ARROW ApS Fusioneret
- ARROW GROUP ApS Active
- ARROW PHARMA ApS Fusioneret
- CP HOLDING I A/S Fusioneret
- SCANDINAVIAN MEDICAL GROUP A/S Fusioneret
- SLAGSLUNDE INVEST ApS Opløst
Terje Aarbogh – 3 other companies
- AARBOGH BUSINESS PARTNER HOLDING ApS Active
- CHR. OLESEN PHARMACEUTICALS A/S Active
- CHR. OLESEN SYNTHESIS A/S Active
Finn Gjersøe – 6 other companies
- AG Københavnsvej ApS Active
- Frederiksdal Klatrepark ApS Active
- Godt i Gang IVS Opløst
- LINDEBLAD ApS Active
- TIL-TOPS ApS Active
- Til Tops Nivå Aps Active
Svend Andersen – 21 other companies
- 2nd G ApS Active
- ACTAVIS A/S Fusioneret
- ACTAVIS NORDIC A/S Fusioneret
- BAVARIAN NORDIC A/S Active
- BIONA A/S Fusioneret
- EUROVITA HOLDING A/S Fusioneret
- FERROSAN HOLDING A/S Fusioneret
- FERROSAN INTERNATIONAL ApS Fusioneret
- FERTIN PHARMA A/S Active
- Falkenhøj Management ApS Active
- GLOBAL AVIATION DATA A/S Active
- KORES NORDIC DANMARK A/S Opløst
- LUNDBECKFOND INVEST A/S Active
- ME AF 30092002 A/S Opløst
- MODUS A/S Active
- MODUS HOLDING A/S Opløst
- OPHTHA A/S Fusioneret
- ORBITA ApS Fusioneret
- RICC A/S Active
- SCAN-VITA INTERNATIONAL A/S Opløst
- THE PANEL ApS Active
Steen Asferg Rasmussen – 30 other companies
- BR MASKINER A/S Opløst
- HAA HOLDCO ApS Opløst
- HAA SNR ApS Opløst
- Magle Biopolymers A/S Active
- NATBI A/S Opløst
- NEWCO AF 21. JUNI 2011 ApS Opløst
- NOVCO HOLDING II A/S Fusioneret
- NOVENCO BUILDING & INDUSTRY A/S Active
- NOVENCO FIRE FIGHTING A/S Opløst
- NOVENCO HAK ApS Active
- NOVENCO MARINE & OFFSHORE A/S Active
- NOVENCO MARINE A/S Opløst
- PK BIOTECH ApS Active
- SNR HOLDCO ApS Active
- Shell Aarhus Biogas A/S Active
- Shell Biogas A/S Active
- Shell Glansager Biogas A/S Active
- Shell Hemmet Biogas ApS Active
- Shell Holsted Biogas A/S Active
- Shell Korskro Biogas A/S Active
- Shell Kværs Biogas A/S Active
- Shell Køng Biogas A/S Active
- Shell Midtfyn Biogas A/S Active
- Shell Månsson Biogas A/S Active
- Shell Nordfyn Biogas A/S Active
- Shell Sdr. Vium Biogas ApS Active
- Shell Vaarst Biogas A/S Active
- Shell Videbæk Biogas A/S Active
- TS DRIFT I A/S Opløst
- WESTRUP APS Active
Mikkel Lyager Olsen – 3 other companies
- ALPHARMA DENMARK ApS Opløst
- PHARMAERO ApS Opløst
- XELLIA GROUP ApS Active
Address history (0 moves)
| Dalslandsgade 11, 2300 København S |
Former names
| XELLIA PHARMACEUTICALS ApS | – now |
| AXELLIA PHARMACEUTICALS ApS | – |
| ALPHARMA ApS | – |
| DUMEX-ALPHARMA ApS | – |
| DUMEX-ALPHARMA A/S | – |
| A/S DUMEX (DUMEX LTD.) | – |
Employees per year
Other companies at the same address
- A.L - PHARMA ApS Fusioneret
- ALPHARMA DENMARK ApS Opløst
- NEW XELLIA GROUP A/S Active
- XELLIA GROUP ApS Active
- XELLIA HOLDCO A/S Active
Similar companies in København
- Roquette Pharma Denmark ApS København V
- Nature's BioCeuticals Denmark ApS København Ø
- Hyaworth ApS København Ø
- MONOZYME ApS Hellerup
- aiwell Nordic ApS København N
- Atlas Growers Denmark A/S København K
- Orenda ApS København S
- Vectocan IVS København K
- TAK Biopharma IVS København N
Questions and answers about XELLIA PHARMACEUTICALS ApS
Has XELLIA PHARMACEUTICALS ApS gone bankrupt?
No, XELLIA PHARMACEUTICALS ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of XELLIA PHARMACEUTICALS ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of XELLIA PHARMACEUTICALS ApS?
Michael Kocher is the CEO of XELLIA PHARMACEUTICALS ApS.
Who is the auditor of XELLIA PHARMACEUTICALS ApS?
XELLIA PHARMACEUTICALS ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was XELLIA PHARMACEUTICALS ApS founded?
XELLIA PHARMACEUTICALS ApS was founded on 31 March 1959.
What is the equity of XELLIA PHARMACEUTICALS ApS?
Equity was DKK 404.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.